A new Practice Review for Heart Failure, with commentary by Prof Andrew Coats.  

Look forward to updates and new treatment guidelines, changes to medicines reimbursement and licensing, educational and professional body news plus plus  our COVID-19 resources for Cardiologists. This issue:

–  Focused update of ESC HF guidelines
–  CPP for avoiding and mitigating HF
–  Managing HFpEF
–  Safety and efficacy of empagliflozin in patients with HFpEF using diuretics
–  Comparison of current HF international guidelines
–  Cardio-obstetrics and HF
–  60-day prescriptions of PBS medicines
–  Semaglutide improves HF and CVD
–  Complete revascularisation impact on HF in patients with ACS and MVD
–  Sex-based differences in acute HF treatment and outcomes
–  COVID-19 resources
–  Conferences, workshops and CPD

Download the Heart Failure Practice_Review_Issue_1